Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

BRIMONIDINE\BRINZOLAMIDE for Psoriasis: Side Effects & Safety Data

Visibly Younger Skin in Weeks

Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.

Discover Synevra

There are 5 adverse event reports in the FDA FAERS database where BRIMONIDINE\BRINZOLAMIDE was used for Psoriasis.

Most Reported Side Effects for BRIMONIDINE\BRINZOLAMIDE

Side Effect Reports % Deaths Hosp.
Treatment failure 373 12.8% 0 0
Ocular hyperaemia 321 11.0% 0 2
Eye irritation 290 10.0% 0 1
Drug ineffective 277 9.5% 1 5
Vision blurred 212 7.3% 0 9
Hypersensitivity 181 6.2% 0 4
Eye pain 165 5.7% 0 3
Visual impairment 152 5.2% 0 8
Intraocular pressure increased 151 5.2% 0 4
Glaucoma 136 4.7% 1 10
Dizziness 121 4.2% 0 13
Eye allergy 108 3.7% 0 0
Drug hypersensitivity 106 3.6% 0 1
Eye pruritus 101 3.5% 0 4
Blindness 82 2.8% 0 9

Other Indications for BRIMONIDINE\BRINZOLAMIDE

Product used for unknown indication (1,885) Glaucoma (582) Open angle glaucoma (156) Intraocular pressure increased (133) Ocular hypertension (95) Intraocular pressure decreased (12) Intraocular pressure test abnormal (10) Postoperative care (10) Colitis ulcerative (9) Angle closure glaucoma (7)

Other Drugs Used for Psoriasis

APREMILAST (76,127) SECUKINUMAB (58,471) ADALIMUMAB (56,634) RISANKIZUMAB-RZAA (40,890) ETANERCEPT (30,483) USTEKINUMAB (21,763) IXEKIZUMAB (16,569) GUSELKUMAB (11,736) CERTOLIZUMAB PEGOL (8,179) METHOTREXATE (6,628)

Related Pages

BRIMONIDINE\BRINZOLAMIDE Full Profile All Psoriasis Drugs BRIMONIDINE\BRINZOLAMIDE Demographics BRIMONIDINE\BRINZOLAMIDE Timeline